Organogenesis Holdings Inc.
ORGO
$1.79
$0.031.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -81.10% | -221.64% | 102.62% | 329.63% | 50.16% |
| Total Depreciation and Amortization | -18.15% | 2.43% | -0.14% | 6.47% | 6.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4,381.14% | -103.55% | 429.43% | -35.20% | -34.37% |
| Change in Net Operating Assets | -88.53% | 261.50% | -46.14% | 21.62% | -84.04% |
| Cash from Operations | -249.82% | -46.41% | 1,180.29% | 109.37% | -64.90% |
| Capital Expenditure | 65.03% | 32.37% | -108.14% | 38.57% | -0.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 65.03% | 32.37% | -108.14% | 38.57% | -0.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 96.46% | -3,158.28% | -2.03% | -2.78% | -1.05% |
| Issuance of Common Stock | -- | -- | -98.46% | -- | -100.00% |
| Repurchase of Common Stock | 100.00% | -3,406.90% | -4,250.00% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -65.99% | -65.58% | 55.95% | -- | -- |
| Cash from Financing | 38.15% | -320.32% | 52.89% | -3,444.10% | 85.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,927.55% | -107.45% | 419.97% | 74.56% | -43.65% |